Last updated: January 21, 2024
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Alopecia
Male Pattern Baldness
Hair Loss
Treatment
5% minoxidil
microneedling
Autologous Concentrated Growth Factor
Clinical Study ID
NCT06218394
20230984
Ages 18-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- age between 18 and 65 years;;
- clinical diagnosis of female pattern hair loss;
- no previous laser treatments for AGA in the past six months before enrollment; 4)willingness to provide pictures and follow-up studies.
Exclusion
Exclusion Criteria:
- if presented with severe diseases of internal organs, eyes, or skin;
- inflammation, infection, or unhealed wounds on the skin around the site of treatmenton the head;
- systematic treatment with corticosteroids or other immunosuppressants andimmunomodulators in the past 3 months.
Study Design
Total Participants: 135
Treatment Group(s): 3
Primary Treatment: 5% minoxidil
Phase:
Study Start date:
December 14, 2023
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Second Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang 310009
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.